IGFBP3 and Alzheimer disease: We can also speculate that cells with suppressed IGFBP3 expression due to Aβ-induced epigenetic modifications could be vulnerable to Aβ toxicity, and chronic exposure to Aβ protein could lead to damage or death in AD-related brain regions.